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Abstract
Background: Primary care physicians need a brief and accurate screening test of dementia. The objective of this
study was to determine whether a short form of Mini-Mental State Examination (SMMSE) was as accurate as the
Mini-Mental State Examination (MMSE) in screening dementia.
Methods: Based on case control design study, SMMSE and MMSE were assessed in 184 community-dwelling older
adults (mean age 81.3 ± 6.5 years, 71.7% women) with memory complaint sent by their primary care physician to
a memory clinic. Included participants were separated into two groups: cognitively healthy individuals and
demented individuals.
Results: The trade-off between sensitivity and specificity of the SMMSE for clinically diagnosed dementia was 4.
Based on the cut-off value ≤ 4 for SMMSE and a cut-off value ≤ 24 for MMSE, the sensitivity of both tests was
similar (89.5% for SMMSE versus 90.0% for MMSE), whereas the specificity, the positive predictive values (PPV) and
the negative predictive values (NPV) were higher for SMMSE compared to MMSE (85.4 versus 75.5% for specificity;
95.5% versus 92.8% for PPV; 70.0 versus 68.9 for NPV). The positive and negative Likehood Ratio (LR) of SMMSE
were higher than those of MMSE (respectively, 6.1 versus 3.7; 8.1 versus 7.7). In addition, odds ratio (OR) for
dementia was higher for the SMMSE compared to the MMSE (OR = 49.8 with 95% confident interval (CI) [18.0;
137.8] versus OR = 28.6 with 95% CI [11.6; 70.3]).
Conclusions: SMMSE seems to be an efficient short screening test for dementia among community-dwelling older
adults with a memory complaint. Further research is needed to confirm its predictive values among unselected
primary care older patients.
Background
Dementia is an acquired clinical syndrome that associ-
ates memory decline and at least one other cognitive
function decline, all disturbing social or daily living
activities [1]. An estimated 50% of patients over 65 are
not diagnosed by their primary care physician, and most
missed cases are mild to moderate [2,3]. As yearly inci-
dence of dementia increases with age, the under-
diagnosis of dementia in primary care will probably
increase in the future [3]. This under-diagnosis is in
part related to a limited time for in-depth consideration
of cognitive difficulties of primary care patients [1-3].
Since 2003, the U.S. preventive services task force
highlighted that the Mini-Mental State Examination
(MMSE) was the best-studied instrument to screen cog-
nitive impairment in selected patients with cognitive
impairment [1]. This test is scored out of 30, a score of
24 or less suggesting dementia [1-3]. Although the
MMSE is the most widely used screening test in specia-
lized clinical setting, it is little used by primary care
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any medium, provided the original work is properly cited.physicians because it is time-consuming (e.g.; around 20
minutes to perform), and is thus hardly practicable dur-
ing routine office visits [3]. Several short screening tests
for dementia have been developed but their positive pre-
dictive values (PPV) were low, calculated around 50%
[1]. Therefore, for dementia screening, primary care
physicians need a brief and accurate screening test,
applicable during clinical practice among patients with
cognitive complaint.
Episodic memory is a memory system that enables
individuals to remember events, times and places
acquired through personal experience. Episodic memory
impairment is the most frequent symptom of dementia
and the most common complaint [1-3]. A brief cogni-
tive test based on the evaluation of episodic memory
impairment with sufficient sensitivity, specificity and
predictive values could therefore serve as a useful
screening tool for dementia. Among the 30 items of the
MMSE that address multiple cognitive domains, 6 items
specifically assessing episodic memory can be fortunately
distinguished [4]. The time needed to complete these 6
episodic memory items is much shorter compared to
the 30 items of the whole MMSE. What is more, since
MMSE is widely used for a long time all over the world
[1-3], physicians usually know it and the way to use it.
These two points suggest that a short test based on the
6 episodic memory items of the MMSE would be easily
used by physicians to detect dementia. Its accuracy
remains yet to be determined. We hypothesized that the
6 memory items of the MMSE could be used alone to
build a Short form of Mini-Mental State Examination
(SMMSE) with sufficient sensitivity, specificity, positive
and negative predictive values to serve as a good screen-
ing test for dementia in older adults with memory com-
plaint. The aim of this study was to determine whether
the SMMSE was as accurate as the MMSE in screening
dementia among older ambulatory participants with a
memory complaint.
Methods
Participants
On hundred eighty four participants (41 cognitively
healthy individuals (CHI) and 143 demented individuals
(DI)) were included in this case control design study
between January 2009 and December 2009, after obtain-
ing their informed consent or the agreement of the
trusted person, as appropriate. Consent forms were
acquired from all participants sent for a memory com-
plaint by their primary care physician to the memory
clinic of Angers University Hospital, France. The eligible
criteria for inclusion in this study were age 65 and over,
ambulatory, adequate ability to understand and speak
French and no acute medical illness in the past month.
The exclusion criteria were active depression and mild
cognitive impairment. The classification of normal cog-
nition and dementia were determined at a weekly inter-
disciplinary conference based on the neuropsychological
and behavioural tests performance, as well as physical
examination findings, blood values and brain imaging
findings. The diagnosis of dementia followed the Diag-
nostic and statistical manual of mental disorders fourth
edition (DSM-IV) criteria [4]. Alzheimer’s disease (AD)
and vascular dementia were diagnosed according to
respectively the NINCDS-ADRDA criteria for probable
AD and the criteria of the DSM-IV [5,6]. This study was
in accordance with the ethical standards set forth in the
declaration of Helsinki (1983). The local ethics commit-
tee of Angers University Hospital (Committee for the
Protection of People West-2, Angers, France) approved
the project.
Neuropsychological evaluation
Neuropsychological evaluation was performed during a
face-to-face examination carried out by a neuropsychol-
ogist. The following standardized tests were used to
probe several aspects of cognitive function: the MMSE
[4], the Cognitive Assessment Battery (CAB) [7], the
Frontal Assessment Battery (FAB) [8], and the Instru-
mental Activities of Daily Living (IADL) [9]. The CAB
assesses cognitive function as a whole (i.e., memory, lan-
guage, praxia, spatiotemporal orientation and reasoning).
It is composed of 96 items and its completion time is
around 45 minutes. Score range varies from 0 to 96,
with 96 indicating a normal cognitive functioning [7].
The FAB is a validated, short bedside questionnaire
designed to assess both cognitive and behavioural
changes in frontal lobe dysfunctions [8]. The FAB is a
scale composed of 6 subtests (conceptualization, mental
shifting, motor programming, sensitivity to interference,
inhibitory control, and environment autonomy). It can
be performed in approximately 10 minutes. Score range
varies from 0 to 18, a score of 18 indicating normal
executive functioning [8]. The IADL is a scale evaluating
the autonomy to perform the instrumental activities of
daily living (i.e., using transportation, managing finances,
using the phone, managing medicines) [9]. Each affected
function is marked 0. Score range varies from 0 to 4, a
score under 3 indicating disability [9].
T h eS M M S Es c o r ew a sb u i l tf r o mt h e6m e m o r y
items of the MMSE. It was calculated following the for-
mula: [immediate recall of 3 words + delayed recall of 3
words]. The score ranged from 0 to 6, with 6 indicating
the best performance.
Statistics
The participants’ baseline characteristics were summar-
ized using means and standard deviations or frequencies
and percentages, as appropriate. Participants were
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between groups were performed using t-test for indepen-
dent samples or Chi-square, as appropriate. Uni and mul-
tiple logistic regression analyses were performed to
specify the association between dementia (dependent
variable) and SMMSE (independent variable) adjusted on
baseline characteristics. Sensitivity analysis consisted of
building a receiver operator curve (ROC) by computing
the sensitivity and specificity of each SMMSE score (from
0 to 6), to determine the most discriminated threshold
maximizing both sensitivity and specificity (Figure 1).
Sensitivity, specificity, PPV, negative predictive value
(NPV), positive and negative likehood ratio (LR), and
odds ratio (OR) for dementia were calculated for the
S M M S Eb a s e do nt h ec u t - o f fv a l u ed e t e r m i n e db yt h e
sensitive analysis, and for the MMSE based on the cut-off
value ≤ 24 [1-3]. P-values < 0.05 were considered as sta-
tistically significant. All statistics were performed using
SPSS (version17.0; SPSS, Inc., Chicago, IL) and Dag-stat
a spreadsheet for the calculation of comprehensive statis-
tics for the assessment of diagnostic tests [10].
Results
The diagnosis of dementia included 53.8% (n = 99) Alz-
heimer’s disease (AD), 14.7% (n = 27) vascular dementia
and 9.2% (n = 17) other dementia. DI were older than
CHI (P < 0.001) and had lower score on MMSE (P <
0.001), SMMSE (P < 0.001), CAB (P < 0.001), FAB (P <
0.001) and IADL (P < 0.001) (Table 1). There was no sig-
nificant between-group difference regarding the other
clinical characteristics. The ROC curve showed an area
of 0.93 for SMME and of 0.95 for MMSE (Figures 1a and
1b). In logistic regression models, SMMSE score was
negatively associated with dementia (P < 0.001) and age
was positively associated with dementia (P < 0.001 for
unadjusted model, P = 0.002 for fully adjusted) (Table 2).
The trade-off between sensitivity and specificity of the
SMMSE for clinically diagnosed dementia was 4. Based
on the cut-off value ≤ 4 for SMMSE and a cut-off value ≤
24 for MMSE, the sensitivity of both tests was similar
(89.5% for SMMSE versus 90.0% for MMSE), whereas the
specificity, the PPV and the NPV were higher for
SMMSE compared to MMSE (respectively, 85.4 versus
75.5% for specificity; 95.5% versus 92.8% for PPV; 70.0
versus 68.9 for NPV). The positive and negative LR of
SMMSE were higher than those of the MMSE (respec-
tively, 6.1 versus 3.7; 8.1 versus 7.7). In addition, OR for
dementia was higher for the SMMSE than the MMSE
(OR = 49.8 with 95% confident interval (CI) [18.0;137.8]
versus OR = 28.6 with 95% CI [11.6;70.3]) (Table 3).
Discussion
Our results showed that the SMMSE score was strongly
associated with the diagnosis of dementia. In addition, a
score ≤ 4 of SMMSE had a higher specificity, PPV, NPV,
positive and negative LR than a MMSE score ≤ 24.
T h eS M M S Ea p p e a r st ob eag o o dn e ws c r e e n i n gt e s t
for dementia among older adults presenting with a
memory complaint. We showed a strong association
between a score ≤ 4 and dementia which is in concor-
dance with previous studies reporting that memory tests
had a high discriminative validity for dementia [1-3,11].
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Figure 1 Receiver operator characteristic curves for SMMSE
and MMSE. a) SMMSE. b) MMSE. SMMSE: Short form of Mini-Mental
State Examination; MMSE: Mini-Mental State Examination; ROC:
Receiver operator curve.
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in older adults, which was the case in our studied sam-
ple [1]. Because memory impairments are highly preva-
lent in AD, it is not surprising that a test based on
memory may screen dementia with a high predictive
v a l u e[ 1 , 1 1 ] .H o w e v e r ,c o m p a r e dt op r e v i o u ss t u d i e s ,
SMMSE did not use an encoding specificity because it
follows the instructions of assessment of MMSE
[1-3,11]. SMMSE thus assesses not only episodic mem-
ory (encoding and retrieval phase) but also semantic
memory, attention and probably executive functions
deficit.
In clinical practice, when older patients present with a
memory complaint, the first issue is to make a diagnosis
and determine whether they are demented or not. A
screening test able to identify patient who have demen-
tia is therefore of prime importance for daily practice
[1,11]. Discriminative validity of SMMSE for dementia
was high compared to MMSE in our study. In addition,
unlike previous short screening tests for dementia,
SMMSE had a higher PPV than MMSE calculated at
95.5 [1]. The SMMSE could thus be used in clinical
practice as an efficient screening test for dementia in
older adults with a memory complaint.
The second issue in primary care settings is related to
the under-diagnosis of dementia [1-3]. Several explana-
tions account for this problem which is not only due to
the lack of diagnostic skill, but rather to a pressure on
time [3]. Because MMSE takes up to 20 minutes to
complete, it may not be practical in primary care prac-
tice. In contrast, SMMSE is shorter to perform, easier
and more accessible compared to MMSE. As a conse-
quence, SMMSE could be proposed to general practi-
tioners as a fast screening tool for dementia.
Our findings showed that DI were older than CHI and
that age was significantly associated with dementia. This
was in concordance with previous studies as it is long
known that the primary risk factor of dementia is the
a d v a n c ei na g e[ 6 , 7 , 1 1 ] .W ea l s or e p o r t e dt h a tt h e r e
were no association between the female gender or the
use of psychoactive drugs and the diagnosis of dementia.
These results were discordant with some previous pub-
lished data having identified female gender as a risk fac-
tor of dementia [12]. Furthermore, demented patients
frequently use psychoactive drugs due to behavioral dis-
orders [13]. An explanation for our mixed results could
r e l yo nt h ef a c tt h a tb o t hg r o u p so fp a r t i c i p a n t sw e r e
old in our study, with a proportion of females using psy-
choactive drugs that is usually high among this popula-
tion [14]. This phenomenon could mask the classical
associations with gender and psychoactive drugs in our
sample of demented patients.
Our study has several limitations. First, we used of a
case control design which may limit the exploration of
the association between SMMSE score and dementia,
compared to a cohort design. Second, although we were
Table 1 Clinical characteristics of studied sample of participants according to diagnostic of dementia (n = 184)
CHI
(n = 41)
DI
(n = 143)
P-value*
Age, mean ± SD (years) 77.7 ± 7.7 82.3 ± 5.7 < 0.001
Female, n (%) 30 (73.2) 102 (71.3) 1.000
Use of psychoactive drugs daily†, n (%) 14 (34.1) 70 (49.0) 0.111
MMSE score (/30 points), mean ± SD 26.7 ± 2.2 19.4 ± 4.1 < 0.001
SMMSE score (/6 points), mean ± SD 5.3 ± 0.7 3.4 ± 0.9 < 0.001
CAB score (/96 points), mean ± SD 84.8 ± 6.3 67.2 ± 11.3 < 0.001
FAB score (/18 points), mean ± SD 14.2 ± 3.2 10.7 ± 2.8 < 0.001
IADL score (/4 points), mean ± SD 3.9 ± 0.3 2.4 ± 0.7 < 0.001
CHI: Cognitively healthy individuals; DI: demented individual; MMSE: Mini-Mental State Examination; SMMSE: Short form of Mini-Mental State Examination
(maximum score of 6 corresponding to best performance); CAB: Cognitive Assessment Battery; FAB: Frontal Assessment Battery; IADL: Instrumental Activities of
Daily Living; *: Comparison based on t-test or Chi-square test, as appropriate; † Use of benzodiazepines or antidepressants or neuroleptics
Table 2 Uni and multivariate logistic regression models showing the association between dementia (dependent
variable) and SMMSE score (independent variable) and adjusted on clinical characteristics (n = 184)
Unadjusted model Fully adjusted model
OR 95% CI P-value OR 95% CI P-value
SMMSE 0.12 [0.07; 0.22] < 0.001 0.10 [0.05; 0.21] < 0.001
Age 1.12 [1.06;1.19] < 0.001 1.17 [1.06;1.29] 0.002
Female 0.91 [0.42;1.99] 0.817 1.29 [0.38;4.42] 0.688
Psychoactive drugs† 1.85 [0.90;3.81] 0.096 1.01 [0.33;3.15] 0.986
SMMSE: Short form of the Mini-Mental State Examination (maximum score of 6 corresponding to best performance); OR: odds ratio; *: Use of benzodiazepines or
antidepressants or neuroleptics; OR and P-value significant (i.e.; P-value < 0.05) indicated in bold.
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the relationship between SMMSE score and dementia,
residual potential confounders may still be present.
Third, SMMSE was built from MMSE score and not
performed as a single test that may probably induce var-
iation in score.
Conclusions
SMMSE seems to be a short screening test for dementia
in older adults with memory complaint. Further
research is needed to confirm its predictive values in
primary care older patients.
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Table 3 Performance of SMMSE and MMSE for the
diagnosis of dementia (n = 184)
SMMSE score ≤
4
MMSE score ≤
24
Sensitivity (%) 89.5 90.0
Specificity (%) 85.4 75.5
Positive predictive value (%) 95.5 92.8
Negative predictive value (%) 70.0 68.9
Likelihood ratio of positive test 6.1 3.7
Likelihood ratio of negative test 8.1 7.7
Odds ratio for dementia [95%
CI]
49.8 [18.0;137.8] 28.6 [11.6;70.3]
SMMSE: Short form of Mini-Mental State Examination
MMSE: Mini-Mental State Examination
CI: Confidence interval
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